Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Asclepius TCG
San Diego, California, United States
- Ownership
- Private
- Employees
- ~15
- Development stage
- Other
01
Overview
Asclepius TCG is a biotechnology company focused on the discovery and development of novel therapeutics for high-need medical areas, including pain management and metabolic diseases. The company leverages its expertise in translational medicine to bridge the gap between early-stage research and clinical application. By targeting specific G protein-coupled receptors and ion channels, Asclepius TCG aims to create more effective and safer treatment options. Their current pipeline is primarily in the pre-clinical stage, focusing on optimizing lead compounds for future clinical trials.
- Therapeutic areas
- ImmunologyNeurologyMetabolic Disorders
- Modalities
- Small moleculePeptides
- Industry
- Biotech
Beyond the preview
Go deeper on Asclepius TCG.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Asclepius TCG.